Indacaterol/Glycopyrronium Is Cost-Effective Compared to Salmeterol/Fluticasone in COPD: FLAME-based Modelling in a Swedish Population
Respiratory Research - United Kingdom
doi 10.1186/s12931-017-0688-5
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2017
Authors
Publisher
Springer Science and Business Media LLC